Aset Bersih saben Siji Saham: OnKure Therapeutics, Inc. (OKUR)

Logo grafis OnKure Therapeutics Inc (OKUR)

The development of OnKure Therapeutics Inc (OKUR) is independent of market cycles, as its success is based on drug trials. However, the absence of commercial revenue creates a financial vacuum. The net book value per share visualizes capital strength, where 4.28 shows the level of this metric. Business growth is constrained by strict FDA regulations and highly complex patent protection within the oncogene sector.

OKUR (OnKure) riwayat Nilai Akuntansi saben Saham saka 08.10.2024 nganti 30.10.2026

Rincian metrik keuangan lan pasar OnKure Therapeutics, Inc. (OKUR)

- rega saham lan prakiraan rega para ahli:
Kutipan saham OnKure|OKUR - Prakiraan konsensus analis
- indikator kapitalisasi bursa perusahaan:
Nilai pasar OnKure Therapeutics Inc|OKUR - Nilai Dipunlarasaken Utang lan Kas
- data nilai buku modal saham:
Nilai Buku saben Saham OnKure Therapeutics|OKUR - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku onkuretherapeutics.com|OKUR - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas OnKure Therapeutics Inc|OKUR - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal OnKure|OKUR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku OnKure Therapeutics Inc|OKUR - Utang jangka dawa|Utang jangka cendhak perusahaan OnKure Therapeutics|Indikator likuiditas cepet onkuretherapeutics.com
- indikator pendapatan resik lan kelipatan nilai:
OKUR - Bathi pungkasan
Analisis wiwitan perusahaan:onkuretherapeutics.com (OKUR)
Produk seri OnKure Therapeutics, Inc.

Institutional capital assesses the attractiveness of OnKure Therapeutics Inc (OKUR) through the lens of investment security amid high binary risks associated with early-stage oncology drug development. By analyzing the current book value per share, investors can identify the remaining equity after all liabilities are settled, allowing them to determine the real value of their ownership stake and evaluate the biotech startup's resilience to potential liquidity shortages.

Pesaing utama

ONC: Nilai Akuntansi saben Saham|HALO - Nilai Buku saben Saham|Revolution Medicines (RVMD) - Aset Bersih saben Siji Saham|ascentage.com - Nilai Akuntansi Saham|CGON (CG Oncology) - Nilai Buku saben Saham|Nilai Akuntansi saben Saham UroGen Pharma Ltd (URGN)|Nilai Buku saben Saham BCAX|Nilai Buku saben Saham Personalis Genomics (PSNL)|Aset Bersih saben Siji Saham Erasca, Inc. ERAS|DCTH: Ekuitas saben Saham|Y-mAbs Therapeutics, Inc. - Nilai Buku saben Saham|Aura Biosciences Inc (AURA) - Nilai Akuntansi saben Saham|CADL: Nilai Buku saben Saham|Nilai Aset Bersih saben Saham Accuray, Inc. (ARAY)|Aset Bersih saben Siji Saham SELLAS Life Sciences Group, Inc.|ACTU: Nilai Akuntansi Saham|Nilai Akuntansi saben Saham CTOR (Citius Oncology)|HURA (tuhurabio.com) - Nilai Akuntansi Saham|Nilai Buku saben Saham TARA (Protara)|FATE - Nilai Akuntansi saben Saham|WHWK: Nilai Akuntansi saben Saham|TCRX - Nilai Buku saben Saham|championsoncology.com (CSBR) - Aset Bersih saben Siji Saham|XBiotech - Nilai Akuntansi Saham|CVM (CEL-SCI Corp.) - Nilai Buku saben Saham|Nilai Aset Bersih saben Saham OS Therapies, Inc. OSTX|Aset Bersih saben Siji Saham Radiopharm Theranostics Limited (RADX)|ARTV - Nilai Aset Bersih saben Saham|Aset Bersih saben Siji Saham Adlai Nortye ANL|VERU: Ekuitas saben Saham|TPST - Aset Bersih saben Siji Saham|XLO - Nilai Buku saben Saham|RENB (renovarobio.com) - Nilai Akuntansi saben Saham|Mural Oncology (MURA) - Nilai Buku saben Saham|Aset Bersih saben Siji Saham Kairos Pharma Limited|GDTC: Nilai Akuntansi Saham|Nilai Buku saben Saham CRIS|APLM - Nilai Aset Bersih saben Saham|Tharimmune, Inc. - Nilai Akuntansi saben Saham|Nilai Akuntansi Saham ADVB|GNPX: Nilai Akuntansi saben Saham|Calidi Biotherapeutics - Rega Buku Saham|SBFM: Nilai Buku saben Saham|Xenetic Biosciences, Inc. - Nilai Akuntansi Saham|SLRX (Salarius Pharmaceuticals) - Nilai Buku saben Saham|Nilai Aset Bersih saben Saham purple-biotech.com PPBT|Aset Bersih saben Siji Saham American Oncology Network (AONC)|BGNE (BeiGene Ltd.) - Nilai Akuntansi Saham|Nilai Buku saben Saham CKPT (Checkpoint Therapeutics, Inc)|Nilai Buku saben Saham elevationoncology.com ELEV|ICAD - Aset Bersih saben Siji Saham|Nilai Buku Saham IKNA|NTBL: Nilai Buku saben Saham|Nilai Aset Bersih saben Saham Viracta Therapeutics, Inc. (VIRX)|Nilai Akuntansi saben Saham MOR|Nilai Buku saben Saham NAYA Biosciences Corp|Nilai Akuntansi saben Saham AAPGV (Ascentage Pharma Group)